|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR977 |
|
Date of registration:
|
16/05/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Second serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.
|
|
Scientific title:
|
Second serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study. - PIENTER 2 |
|
Date of first enrolment:
|
6/2/2006 |
|
Target sample size:
|
7700 |
|
Recruitment status: |
complete |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=977 |
|
Study type:
|
intervention |
|
Study design:
|
Randomised: No; Masking: None; Control: Not applicable; Group: [default]; Type: Single arm
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
F.R.M
Klis, van der |
|
Address:
|
RIVM, afd. LIS
P.O. Box 1
3720 BA
Bilthoven
The Netherlands |
|
Telephone:
|
(+31) 30 2742272 |
|
Email:
|
fiona.van.der.klis@rivm.nl |
|
Affiliation:
|
|
|
|
Name:
|
F.R.M
Klis, van der |
|
Address:
|
RIVM, afd. LIS
P.O. Box 1
3720 BA
Bilthoven
The Netherlands |
|
Telephone:
|
(+31) 30 2742272 |
|
Email:
|
fiona.van.der.klis@rivm.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Subject is part of the study sample;
2. Aged 0-79 years old;
3. Has received a personal invitation for the study;
4. Subject has given written informed consent before start of the study.
Exclusion criteria: 1 Subject is an employee of the RIVM.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
Infectious diseases, Vaccines, National immunisation program
|
|
Intervention(s)
|
|
A blood sample and a questionnaire regarding health perception, diseases (including sexually transmitted), vaccination data.
|
|
Primary Outcome(s)
|
|
The age-specific seroprevalence (immunity) for diseases included in the National Immunisation Program of the Dutch general population.
|
|
Secondary Outcome(s)
|
1. The age-specific seroprevalence against other infectious diseases, in particular those that might be vaccin preventable in the near future and against those diseases with a frequent subclinical course.
2. The age-specific seroprevalence amongst the allochtonous populations (additional sample).
3. The age-specific seroprevalence amongst non-vaccinated orthodox reformed individuals (additional sample).
|
|
Secondary ID(s)
|
|
ISRCTN20164309
|
|
N/A
|
|
Source(s) of Monetary Support
|
|
Dutch Ministry of Health, Welfare and Sport
|
|